Cargando…
Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice
OBJECTIVES: Patients with type 2 diabetes mellitus (T2DM) exhibit strong insulin resistance or abnormal insulin production. Probiotics, which are beneficial live micro-organisms residing naturally in the intestinal tract, play indispensable roles in the regulation of host metabolism. However, the de...
Autores principales: | Hsieh, Pei-Shan, Ho, Hsieh-Hsun, Hsieh, Shih-Hung, Kuo, Yi-Wei, Tseng, Hsiu-Ying, Kao, Hui-Fang, Wang, Jiu-Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202753/ https://www.ncbi.nlm.nih.gov/pubmed/32332068 http://dx.doi.org/10.1136/bmjdrc-2019-001028 |
Ejemplares similares
-
In vitro antagonistic growth effects of Lactobacillus fermentum and lactobacillus salivarius and their fermentative broth on periodontal pathogens
por: Chen, Ling-Ju, et al.
Publicado: (2012) -
A Three-Arm, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Lactobacillus salivarius AP-32 and Bifidobacterium animalis CP-9 Used Individually in Healthy Infants
por: Chen, Jui-Fen, et al.
Publicado: (2023) -
Lactobacillus reuteri TSR332 and Lactobacillus fermentum TSF331 stabilize serum uric acid levels and prevent hyperuricemia in rats
por: Kuo, Yi-Wei, et al.
Publicado: (2021) -
Adjuvant Probiotics of Lactobacillus salivarius subsp. salicinius AP-32, L. johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9 Attenuate Glycemic Levels and Inflammatory Cytokines in Patients With Type 1 Diabetes Mellitus
por: Wang, Chung-Hsing, et al.
Publicado: (2022) -
Lactobacillus salivarius Subspecies salicinius SA-03 is a New Probiotic Capable of Enhancing Exercise Performance and Decreasing Fatigue
por: Lee, Mon-Chien, et al.
Publicado: (2020)